SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
06-Feb-24 10:27 AM View: | Cns Pharmaceuticals, Inc. (CNSP) | 01-Feb-24 | Private Purchase | 66,666 | $0.30 | $19,999.80 | 181% 36.77K to 103.44K | |
23-Aug-23 8:00 AM View: | Cns Pharmaceuticals, Inc. (CNSP) | 22-Aug-23 | Purchase | 27,000 | $1.27 | $34,176.60 | 276% 9.77K to 36.77K | |
01-May-23 10:00 PM View: | Cns Pharmaceuticals, Inc. (CNSP) | 28-Apr-23 | Option Exercise | 521 | -- | -- | 6% 9.25K to 9.77K | |
18-Apr-23 8:00 AM View: | Cns Pharmaceuticals, Inc. (CNSP) | 17-Apr-23 | Purchase | 3,100 | $3.20 | $9,920.00 | 50% 6.15K to 9.25K | |
10-Feb-23 5:34 PM View: | Ebet, Inc. (EBET) | 09-Feb-23 | Option Exercise | 6,300 | -- | -- | 100% 0 to 6.3K | |
14-Mar-22 9:40 AM View: | Cns Pharmaceuticals, Inc. (CNSP) | 11-Mar-22 | Grant | 33,000 | $0.31 | $10,230.00 | 22% 151.5K to 184.5K | |
07-Dec-21 8:30 AM View: | Cns Pharmaceuticals, Inc. (CNSP) | 06-Dec-21 | Market Purchase | 5,000 | $0.94 | $4,701.50 | 3% 146.5K to 151.5K | (< 1%) |
22-Nov-21 8:47 AM View: | Cns Pharmaceuticals, Inc. (CNSP) | 19-Nov-21 | Market Purchase | 4,500 | $1.15 | $5,191.65 | 3% 142.0K to 146.5K | (1%) |
25-Aug-20 7:11 PM View: | Cns Pharmaceuticals, Inc. (CNSP) | 24-Aug-20 | Purchase | 142,000 | $2.04 | $289,680.00 | 100% 0 to 142.0K | |
16-Aug-17 6:31 PM View: | Infusystem Holdings, Inc (INFU) | 14-Aug-17 | Market Purchase | 7,900 | $1.90 | $15,010.00 | 38% 20.94K to 28.84K | 917% |